Флавоноиды глазами фармаколога. Особенности и проблемы фармакокинетики

Обложка

Цитировать

Полный текст

Аннотация

Обзор литературы посвящен вопросам фармакокинетики шести основных подклассов флавоноидов: их распространению, потреблению и метаболизму. Особое внимание уделяется проблеме биодоступности этих растительных полифенольных соединений, различию эффектов, полученных в экспериментах in vitro и in vivo. Обсуждается зависимость эффективности флавоноидов от особенностей процессов их метаболизма в организме человека. Особо подчеркивается роль эпителия тонкой кишки и микробиоты толстого кишечника в обеспечении биологической активности флавоноидов.

Об авторах

Яков Федорович Зверев

ФГБОУ ВО «Алтайский государственный медицинский университет» Минздрава РФ

Автор, ответственный за переписку.
Email: zver@agmu.ru

д-р мед. наук, профессор кафедры фармакологии

Россия, 656038, г. Барнаул, ул. Ленина, 40

Список литературы

  1. Спрыгин В.Г., Кушнерова Н.Ф. Природные олигомерные проантоцианидины — перспективные регуляторы метаболических нарушений // Вестник ДВО РАН. – 2006. – № 2. – С. 81–90. [Sprygin VG, Kushnerova NF. Natural oligomeric proanthocyanidins – promising re gulators of metabolic disorders. Vestnik DVO RAN. 2006;(2):81-90. (In Russ.)]. http: //www.cnb.dvo.ru/vestnik/index.htm.
  2. Agati G, Brunetti C, Di Ferdinando M, et al. Functional roles of flavonoids in photoprotection: New evidence, lessons from past. Plant Physiol Biochem. 2013;72:35-45. doi: 10.1016/j.plaphy.2013.03.014. Epub 2013 Mar 28.
  3. Bang SH, Hyun YJ, Shim J, et al. Metabolism of rutin and poncirin by human intestinal microbiota and cloning of their metabolizing α-L-rhamnosidase from Bifidobacterium dentium. J Microbiol Biotechnol. 2015;25(1):18-25. doi: 10.4014/jmb.1404.04060.
  4. Barnes S. The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymph Res Biol. 2010;8(1):89-98. doi: 10.1089/Irb.2009.0030.
  5. Barnes S, Prasain J, D’Alessandro T, et al. The metabolism and analysis of isoflavones and other dietary polyphenols in foods and biological systems. Food Funct. 2011;2(5): 235-44. doi: 10.1039/c1fo10025d. Epub 2011 May 9.
  6. Beecher GR. Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr. 2003;3:3248S-54S. PMID: 14519822.
  7. Braune A, Blaut M. Bacterial species involved in the human gut. Gut Microbes. 2016;7(3):216-34. doi: 10.1080/ 19490976.2016.1158395. Epub 2016 Mar 10.
  8. Burdulis D, Šarkinas A, Jasutiene I, et al. Comparative study of anthocyanin composition, antimicrobal and antioxidant activity in bilberry (Vaccinium myrtillus L.) and blueberry (Vaccinium corymbosum L.) fruits. Acta Pol Pharm.-Drug Res. 2009;66(4):399-408. PMID: 19702172.
  9. Cani PD, Delzenne NM. The role of the gut microbiota in energy metabolism and metabolic disease. Curr Pharm Des. 2009;15:1546-58. doi: 10.2174/138161209788168164.
  10. Chen J, Lin H, Hu M. Metabolism of flavonoids via enteric recycling: Role of intestinal disposition. J Pharmacol Exp Ther. 2003;304(3):1228-35. doi: 10.1124/jpet.102.046409.
  11. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: Chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26(8):1001-43. doi: 10.1039/b802662a. Epub 2009 May 13.
  12. D’Archivio M, Filesi C, Di Benedetto R. Polyphenols, dietary sources and bioavailability. Ann Ist Super Sanita. 2007;43(4):348-61. PMID: 18209268.
  13. Day AJ, Cañada FJ, Diaz JC. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000;468(2-3): 166-70. doi: 10.1016/S0014-5793(00)01211-4. Epub 2000 Feb 22.
  14. Deprez S, Mila I, Huneau JF. Transport of proanthocyanidin dimer, trimer, and polymer across monolayers of human intestinal epithelial Caco-2 cells. Antiox Redox Signaling. 2001;3(6):957-67. doi: 10.1089/152308601317203503. Epub 2004 Jul 5.
  15. Donovan JL, Crespy V, Manach C. Catechin is metabolized by both the small intestine and liver of rats. J Nutr. 2001;131(6):1753-57. PMID: 11385063.
  16. Duda-Chodak A, Tarko T, Satora P, Sroka P. Interaction of dietary compounds, especially polyphenols, with the intestinal microbiota: A Review Eur J Nutr. 2015;54:325-41. doi: 10.1007/s00394-015-0852-y. Epub 2015 Feb 12.
  17. Franke AA, Lai JF, Halm BM. Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake. Arch Biochem Biophys. 2014;559:24-8. doi: 10.1016/ j.abb.2014.06.007. Epub 2014 Jun 16.
  18. Gee JM, DuPont MS, Day AJ. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr. 2000;130(11):2765-71. PMID: 11053519.
  19. Gerristen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr. 2011;6:209-40. doi: 10.1007/s12263-011-0229-7. Epub 2011 May 27.
  20. Graefe EU, Wittig J, Mueller S, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001;41(5):492-99. doi: 10.1177/ 00912700122010366. Epub 2001 May.
  21. Hao WL, Lee YK. Microflora of the gastrointestinal tract: A review. Methods Mol Biol. 2004;268:491-502. doi: 10.1385/1-59259-766-1:491.
  22. Hollman PC, Buijsman MN, van Gameren Y, et al. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res. 1999;31:569-73. PMID: 10630681.
  23. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115-18. doi: 10.1126/science.1058709.
  24. Huber GM, Rupasinghe HPV. Phenolic profiles and antioxidant properties of apple skin extracts. J Food Sci. 2009; 74:693-99. doi: 10.1111/j.1750-3841.2009.01356.x.
  25. Jiang N, Doseff AI, Grotewold E. Flavones: From biosynthesis to health benefits. Plants (Basel). 2016;5(2):27. doi: 10.3390/plants 5020027. Epub 2016 Jun 21.
  26. Kottra G, Daniel H. Flavonoid glycosides are not transported by the human Na+/glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J Pharmacol Exp Ther. 2007;322(2):829-35. doi: 10.1124/jpet.107.124040. Epub 2007 May 10.
  27. Kozlowska A, Szostak-Wegierek D. Flavonoids – food sources and health benefits. Rocz Panstw Zakl Hig. 2014;65(2):79-85. PMID: 25272572.
  28. Kroon PA, Clifford MN, Crozier A, et al. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr. 2004;80(1):15-21. PMID: 15213022.
  29. Lago JHG, Toledo-Arruda AC, Mernak M, et al. Structure-activity association of flavonoids in lung diseases. Molecules. 2014;19(3):3570-95. doi: 10.3390/molecules19033570.
  30. Landete JM. Updated knowledge about polyphenols: Functions, bioavailability, metabolism, and health. Crit Rev Food Sci Nutr. 2012;52(10):936-48. doi: 10.1080/ 10408398.2010.513779.
  31. Li AN, Li S, Zhang YJ, et al. Resources and biological activities of natural polyphenols. Nutrients. 2014;6(12): 6020-47. doi: 10.3390/nu6126020.
  32. Liu Y, Hu M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab Dispos. 2002;30(4):370-77. doi: 10.1124/dmd.30.4.370.
  33. Manach C, Williamson G, Morand C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies 1-3. Am J Clin Nutr. 2005; 81(1 Suppl):230S-42S. PMID: 15640486.
  34. Marín L, Miguelez EM, Villar CJ, Lombo F. Bioavailability of dietary polyphenols and gut microbiota metabolism: Antimicrobal properties. BioMed Res Int. 2015. doi: 10.1155/2015/905215, Article ID 905215, 18 pages. Epub 2015 Feb 23.
  35. Mori M, Yoshida K, Ishigaki Y, et al. UV-B protective effect of a polyacylated anthocyanin, HBA, in flower petals of the blue morning glory, Ipomoea tricolor cv. Heavenly Blue. Bioorg Med Chem. 2015;13(6):2015-20. doi: 10.1016/ j.bmc.2005.01.011.
  36. Nakagawa K, Okuda S, Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci Biotechn Biochem. 1997;61(12):1981-85. doi: 10.1271/bbb.61.1981.
  37. Nemeth K, Plumb GW, Berrin JG, et al. Deglycosylation by small intestinal epithelial cell b-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr. 2003;42(1):29-42. doi: 10.1007/s00394-003-0397-3.
  38. Ohnishi-Kamcyama M, Yanagida A, Kanda T, Nagata T. Identification of catechin oligomers from apple (Malus pumila cv. Fuji) in matrix assisted laser desorption/ioni zation time-of-flight mass spectrometry. Rapid Commun Mass Spectrom. 1997;11:31-6. doi: 10.1002/(SICI)1097-0231(19970115)11:1<31::AID-RCM784>3.0.CO:2-T.
  39. O’Leary KA, Day AJ, Needs PW, et al. Flavonoid glucuronides are substrates for human liver β-glucuronidase. FEBS Lett. 2001;503(1):103-6. doi: 10.1016/S0014-5793(01)02684-9.
  40. O’Leary KA, Day AJ, Needs PW. Metabolism of quercetin glucuronides in an in vitro cell model. In: Biologically-active phytochemicals in foods: analysis, metabolism, bioavailability and function. Ed. by W. Pfaunhauser, G.R. Fenwick, S. Khokhar. Cambridge: Royal Soc. of Chem; 2001. P. 441-442.
  41. Otaki N, Kimira M, Katsumata S. Distribution and major sources of flavonoid intakes in the middle-aged Japanese women. J Clin Biochem Nutr. 2009;44(3):231-38. doi: 10.3164/jcbn.08-231. Epub 2009 Apr 25.
  42. Ozdal T, Sela DA, Xiao J, et al. The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients. 2016;8:78. doi: 10.3390/nu8020078. Epub 2016 Feb 6.
  43. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomics sequencing. Nature. 2010;464(7285):59-65. doi: 10.1038/nature08821.
  44. Rafii F. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Metabolites. 2015;5:56-73. doi: 10.3390/metabo5010056.
  45. Rangel-Huerta OD, Pastor-Villaescusa B, Aguilera CM, Gil A. A systemic review of the efficacy of bioactive compounds in cardiovascular disease: Phenolic compounds. Nutrients. 2015;7:5177-5216. doi: 10.3390/nu7075177.
  46. Richelle M, Pridmore-Merten S, Bodenstab S, et al. Hydrolysis of isoflavone glycosides to aglycones by β-glucosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr. 2002;13(9):2587-92. PMID: 12221213.
  47. Romano B, Pagano E, Montanaro V, et al. Novel insights into the pharmacology of flavonoids. Phytother Res. 2013;27(11):1588-96. doi: 10.1002/ptr.5023. Epub 2013 Jul 4.
  48. Rusznyak SP, Szent-Gyorgi A. Vitamin P: Flavones as vitamins. Nature. 1936;138:27.
  49. Somerset SM, Johannot L. Dietary flavonoid sources in Australian adults. Nutr Cancer. 2008;60:442-49.
  50. Tangney C, Rasmussen HE. Polyphenols, inflammation, and cardiovascular disease. Curr Atheroscler Rep. 2013;15(5):324. doi: 10.1007/s11883-013-0324-x.
  51. Testa R, Bonfigli AR, Genovese S, et al. The possible role of flavonoids in the prevention of diabetic complications. Nutrients. 2016;8(5):310. doi: 10.3390/nu8050310.
  52. Thilakarathna SH, Rupasinghe HPV. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. 2013;5:3367-87. doi: 10.3390/nu5093367.
  53. Vogiatzoglu A, Mulligan AA, Lenjes MAH, et al. Flavonoid intake in European adults (18 to 64 years). PLoS One. 2015;10(5):e0128132. doi: 10.1371/journal.pone. 0128132.
  54. Vrhovsek U, Rigo A, Tonon D, Mattivi F. Quantitation of polyphenols in different apple varieties. J Agric Food Chem. 2004;52:6532-38. doi: 10.1021/jf049317z.
  55. Wallace TC, Slavin M, Frankenfeld CL. Systematic review of anthocyanins and markers of cardiovascular disease. Nutrients. 2016;8:32. doi: 10.3390/nu8010032.
  56. Walle T. Serial review: Flavonoids and isoflavones (phytoestrogens): Absorption, metabolism, and bioactivity. Free Radic Biol Med. 2004;36:829-37. doi: 10.1016/ j.freeradbiomed.2004.01.002.
  57. Williamson G. The use of flavonoid aglycones in vitro systems to test biological activities: Based on bioavailability data, is this a valid approach? Phytochem Rev. 2002;1:215-22.
  58. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies 1-4. Am J Clin Nutr. 2005;81(Suppl.):243S-55S. PMID: 15640487.
  59. Yang Z, Kulkarni K, Zhu W, Hu M. Bioavailability and pharmacokinetics of genistein: Mechanistic studies on its ADME. Anticancer Agents Med Chem. 2012;12(10): 1264-80. PMCID: PMC4010305.
  60. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raven tos RM, et al. Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J Am Diet Assoc. 2010;110(3):390-98. doi: 10.1016/ j.jada.2009.11.024.
  61. Zhang Y, Li Y, Cao C, et al. Dietary flavonol and flavone intakes and their major food sources in Chinese adults. Nutr Cancer. 2010;62(8):1120-27. doi: 10.1080/ 01635581.2010.513800.
  62. Zhu B, Wang X, Li L. Human gut microbiome: The second genome of human body. Protein Cell. 2010;1(8): 718-25. doi: 10.1007/s13238-010-0093-z. Epub 2010 Aug 28.

© Зверев Я.Ф., 2017

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution 4.0 International License.
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).